Search - tctmd.com

Displaying 21 - 40 of 162

Sort: Relevancy | Date

News Conference News EuroPCR 2020

‘Suboptimal’ Outcomes in Real-world Mitral Valve-in-Valve, Valve-in-Ring: VIVID Registry

Yael L. Maxwell

July 01, 2020

News Daily News

Preemptive Stents Feasible for TAVR Patients at High Risk for Coronary Occlusion

Yael L. Maxwell

February 14, 2020

Presentation Live Valves 2019

Failed Aortic Valve Bioprostheses: Valve-in-Valve or Redo-SAVR?

Presenter: Danny Dvir

December 10, 2019

Presentation Live Valves 2019

How Should We Assess Bioprosthetic Valve Durability?

Presenter: Danny Dvir

December 10, 2019

Presentation TVT 2019

Cadaveric Heart Model: Heart Dissection

Presenter: Danny Dvir

June 14, 2019

Presentation TVT 2019

Lessons From the Global Aortic VIVID Registry: Optimizing Procedural Outcomes

Presenter: Danny Dvir

June 13, 2019

Presentation TVT 2019

Redo TAVR: What Is the Experience?

Presenter: Danny Dvir

June 13, 2019

Presentation TVT 2019

Durability of Transcatheter Valves: How Do We Define It, and What Do We Know?

Presenter: Danny Dvir

June 13, 2019

Presentation TVT 2019

Splitting Leaflets. BASILICA to Reduce the Risk of Coronary Obstruction During VIV (and Other TAVR) Procedures

Presenter: Danny Dvir

June 13, 2019

News Daily News

FORWARD Registry: Low Mortality Rate Seen 1 Year After TAVR With Evolut R

Todd Neale

November 20, 2018

Presentation TCT 2018

Update on Valve-in-Valve and Valve-in-Ring Outcomes

Presenter: Howard C. Herrmann, Vinod H. Thourani, Danny Dvir

September 24, 2018

News Daily News

Valve-in-Valve TAVR Meets ‘Benchmark’ Set by Native-Valve Cases for Safety, Effectiveness

Caitlin E. Cox

July 16, 2018

Presentation The Structural Heart Disease Summit 2018

Case #3: A Small (Undersized) Surgical Bioprosthesis

Presenter: Michael J. Reardon, Adnan K. Chhatriwalla, Danny Dvir, Ariel Finkelstein, Kendra J. Grubb, Michael J. Mack, Thomas Modine, Mark J. Russo

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Case #2: A Stentless (or Stented With Leaflets Outside the Stent) Surgical Bioprosthesis

Presenter: Brian K. Whisenant, Adnan K. Chhatriwalla, Danny Dvir, Ariel Finkelstein, Kendra J. Grubb, Michael J. Mack, Thomas Modine, Mark J. Russo

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Case #1: A Poorly Visible Surgical Bioprosthesis

Presenter: Isaac George, Adnan K. Chhatriwalla, Danny Dvir, Ariel Finkelstein, Kendra J. Grubb, Michael J. Mack, Thomas Modine, Mark J. Russo

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Recent Lessons from the Global Aortic VIVID Registry Optimizing Procedural Outcomes

Presenter: Vinayak Bapat, Ran Kornowski, Danny Dvir

June 21, 2018

News Conference News CRT 2018

Ticagrelor: Better Platelet Blockade Post-TAVR?

Michael O'Riordan

March 07, 2018

News Conference News CRT 2018

Early Results for Dock-Plus-Valve Approach Promising in Transcatheter Mitral Valve Replacement

Shelley Wood

March 07, 2018

News Conference News CRT 2018

Transcatheter Fix for Native Aortic Valve Regurgitation ‘Not Optimal’ but Getting Better

Shelley Wood

March 05, 2018

News Daily News

Structural Valve Degeneration: VIVID Group Proposes New, Graduated Definition

Michael O'Riordan

January 26, 2018

Advertisement

‘Suboptimal’ Outcomes in Real-world Mitral Valve-in-Valve, Valve-in-Ring: VIVID Registry

Preemptive Stents Feasible for TAVR Patients at High Risk for Coronary Occlusion

Failed Aortic Valve Bioprostheses: Valve-in-Valve or Redo-SAVR?

How Should We Assess Bioprosthetic Valve Durability?

Cadaveric Heart Model: Heart Dissection

Lessons From the Global Aortic VIVID Registry: Optimizing Procedural Outcomes

Redo TAVR: What Is the Experience?

Durability of Transcatheter Valves: How Do We Define It, and What Do We Know?

Splitting Leaflets. BASILICA to Reduce the Risk of Coronary Obstruction During VIV (and Other TAVR) Procedures

FORWARD Registry: Low Mortality Rate Seen 1 Year After TAVR With Evolut R

Update on Valve-in-Valve and Valve-in-Ring Outcomes

Valve-in-Valve TAVR Meets ‘Benchmark’ Set by Native-Valve Cases for Safety, Effectiveness

Case #3: A Small (Undersized) Surgical Bioprosthesis

Case #2: A Stentless (or Stented With Leaflets Outside the Stent) Surgical Bioprosthesis

Case #1: A Poorly Visible Surgical Bioprosthesis

Recent Lessons from the Global Aortic VIVID Registry Optimizing Procedural Outcomes

Ticagrelor: Better Platelet Blockade Post-TAVR?

Early Results for Dock-Plus-Valve Approach Promising in Transcatheter Mitral Valve Replacement

Transcatheter Fix for Native Aortic Valve Regurgitation ‘Not Optimal’ but Getting Better

Structural Valve Degeneration: VIVID Group Proposes New, Graduated Definition

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content